Lymphoma Clinical Trials in Atlanta

Showing 501-520 of 632 trials

Improving Patient Education for Lymphoma and Leukemia Inpatients

NCT02642510

The purpose of this study is to evaluate the impact of a structured, DVD educational intervention about what to expect during inpatient treatment of a newly diagnosed cancer. The focus of the study will be newly diagnosed lymphoma and acute leukemia patients and their family members. Outcome variables will be the patient and family member's satisfaction with inpatient teaching and anxiety about inpatient treatment.

LeukemiaLymphoma

Emory University78 participantsStarted Jun 2014

Atlanta, Georgia, United States

COMPLETEDPhase 3< 1 mile

Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer

NCT00053053

RATIONALE: Nutritional supplements may help prevent loss of appetite, weight loss, and fatigue in patients with advanced cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two nutritional supplements in preventing loss of appetite, weight loss, and fatigue in patients who have stage III or stage IV solid tumors.

CachexiaLymphomaLymphoproliferative Disorder+1 more

Radiation Therapy Oncology Group472 participantsStarted Dec 2002

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +247 more locations

Improving Patient Education for Lymphoma and Leukemia Inpatients

Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer

Lymphoma Trials in Other Cities

A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma

A Phase I/II Trial of VR-CHOP in Lymphoma Patients

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma

Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease

A Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent Lymphoma

A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma

Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment

Epoetin Alfa in Treating Anemia in Patients With Solid Tumors

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma

Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

Cladribine in Patients With Mantle Cell Lymphoma

Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients

A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies

A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma

Other Conditions in Atlanta